The issue of polypharmacy and inappropriate medication use in post-acute and long-term care (PALTC) has been an ongoing concern. The PALTC setting has one of the highest polypharmacy rates, which increases the risk for adverse events and drug interactions.
Since May 2021, AMDA and ASCP have been holding meetings and developing resources to help prescribers, pharmacists, DONs, CNOs, CMOs, and CEOs optimize medication use in the long-term care setting. This is the recording of this topic's session.
For more resources visit the Drive to Deprescribe page HERE
This activity is not for credit.